Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Added: 5 months ago Source:  Radcliffe CVRM
A new study has explored the underlying mechanisms by which semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), improves outcomes in patients with metabolic dysfunction-associated steatohepatitis (MASH).¹ The research, which combined analysis of a phase 2 clinical trial with preclinical models, identified a unique proteomic signature associated with treatment and suggests that… View more
Research Area(s) / Expertise:

Expertise

Dr Justin Davies is a Senior Research Fellow and Consultant Cardiologist at Imperial College London. He also completed his undergraduate training and continued on to complete his PhD at Imperial after being awarded a British Heart Foundation research fellowship. Now a leading clinical academic in the field of interventional cardiology, Dr Davies has pioneered several new techniques, including… View more
Author(s): William McIntyre Added: 1 year ago
EHRA 24 - Investigator, Dr William McIntyre (Population Health Research Institute, CA) joins us to discuss the findings from a substudy of ARTESiA (NCT01938248).ARTESiA was a randomized, parallel assignment clinical trial which aimed to assess if apixaban could reduce the risk of ischemic stroke and systemic embolism in patients with subclinical atrial fibrillation (AF) and additional risk… View more
Author(s): Anjali T Owens Added: 3 months ago
Navigate the rapidly evolving treatment landscape for hypertrophic cardiomyopathy with Dr Anjali Tiku Owens, a renowned expert in inherited cardiovascular diseases and advanced heart failure.This comprehensive presentation, part of the Cardiomyopathies track of Women As One's CLIMB® 2025 Skills Training Program, explores both established and emerging therapeutic approaches for obstructive and non… View more
Author(s): Nir Uriel Added: 3 months ago
HFSA 25 - CCM-D was associated with successful defibrillation and symptom improvement in patients with HFrEF at 6 months in the INTEGRA-D Trial.Dr Nir Uriel (NewYork-Presbyterian, Columbia University Irving Medical Center, US) joins us to discuss findings from the Integra-D trial, evaluating a novel implantable device that provides both cardiac contractility modulation and defibrillation… View more
Research Area(s) / Expertise:

Atrial Fibrillation

Job title: Associate Professor of Medicine; Laureate Chair in Molecular Medicine; Vice Chief, Cardiovascular Section
Dr Stavrakis is a clinical cardiac electrophysiologist and Associate Professor of Medicine at the University of Oklahoma Health Sciences Center. He is also the Director of Cardiovascular Research at the University of Oklahoma. Dr Stavrakis’ research has focused on autonomic modulation for the treatment of arrhythmias and other cardiovascular diseases, in both animal models and humans. The… View more
Job title: Professor of Anesthesiology and Physiology
Job title: Consultant Cardiologist
Dr Jaswinder Singh Gill qualified from Cambridge University in 1979 and was appointed Consultant Cardiologist to Guy’s & St Thomas’ NHS Trust in 1995. Dr Gill has set up the electrophysiology unit and arrhythmia services for Guy’s & St Thomas’ NHS Trust. His special interests are in the treatment of arrhythmias including radio frequency ablation and the implantation of pacemakers and… View more
Author of more than 120 scientific communications (of which more than 50 in International Congresses). Author of more than 20 articles published, most in International journals Associate investigator of multiple multicentre clinical trials and national and international registries Assistant of the course of Introduction to the Clinic (3rd year, Faculty of Medicine of Lisbon). Professor and… View more